YP
IHE icon

YANKCOM Partnership’s iShares US Pharmaceuticals ETF IHE Stock Holding History

YANKCOM Partnership’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.02K Hold
81
– – ﹤0.01% 268
2026
Q1 		$7.02K Hold
81
– – ﹤0.01% 292
2025
Q4 		$6.87K Hold
81
– – ﹤0.01% 299
2025
Q3 		$5.88K Hold
81
– – ﹤0.01% 256
2025
Q2 		$5.31K Hold
81
– – ﹤0.01% 255
2025
Q1 		$5.71K Buy
+81
New +$5.63K ﹤0.01% 251

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $497M AUM 52.58% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
FP
FFG Partners Fort Lauderdale, Florida $352M AUM 70.53% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

YANKCOM Partnership's IHE Position: Q2 2026 in Review

YANKCOM Partnership held its iShares US Pharmaceuticals ETF (IHE) position steady in Q2 2026 at 81 shares worth $8.02K. The position accounts for ﹤0.01% of the portfolio, ranked #268.

YANKCOM Partnership first reported a position in IHE in Q1 2025 and has held it in 6 quarters since. 115 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • YANKCOM Partnership held 81 shares of iShares US Pharmaceuticals ETF worth $8.02K as of Q2 2026.
  • YANKCOM Partnership left its iShares US Pharmaceuticals ETF share count unchanged in Q2 2026.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of YANKCOM Partnership's portfolio in Q2 2026, its #268 holding.
  • YANKCOM Partnership first reported a position in iShares US Pharmaceuticals ETF in Q1 2025 and has held it in 6 quarters since.
  • 115 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on YANKCOM Partnership's 13F filing for Q2 2026, filed 21 Jul 2026.